Broughton: How to design a robust CBD testing strategy
Libby Clarke, managing consultant for Toxicology at Broughton, explores how CBD companies can optimise their testing strategies.
24 results for “testing”
Libby Clarke, managing consultant for Toxicology at Broughton, explores how CBD companies can optimise their testing strategies.
Black babies were disproportionately more likely to be drug tested than White, before and after cannabis legalisation.
Campaigners have raised serious concerns over the UK’s approach to drug testing.
The study showed that CBD may remain in the blood for a long period of time.
Drug-testing for cannabis should be discontinued for nurses with a documented medical condition
What employees should tell employers, and what employers can legally ask.
Sean McKinley of Originals CBD explores the emerging dangers of synthetic and semi-synthetic cannabinoids in Europe, both for businesses and consumers.
‘Without a clear policy, employers are more likely to be influenced by their understanding of recreational drug use.’
Ask any UK cannabis clinic which conditions bring people through the door, and ADHD will reliably be near the top of the list. Despite this demand, the published literature on […]
Introducing The Medical Cannabis Employer Handbook
ADHD is one of the most commonly reported reasons people seek medical cannabis, but does the evidence support it?
The death of Patrick Navarro has reignited concerns over discrimination in transplant eligibility.
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
The company has cleared the final regulatory hurdle to begin its ENDOCAN Phase 2 trial in women with endometriosis-associated pain.
A comprehensive guide on how to read and interpret cannabis research.
A balanced CBD and THC cannabis flower was found to be more effective for treating acute migraine symptoms than a placebo.
The team at Prohibition Partners shares how they think things will shape up for medical cannabis in 2026.
Dr Simon Erridge reflects on some of the key findings published on medical cannabis this year.
Lab studies find that a combination of THC and CBD kills ovarian cancer cells without harming healthy cells
The event brought together expert medical and scientific voices and powerful patient perspectives.
A new report from the General Pharmaceutical Council’s (GPhC) provides the most detailed regulatory snapshot yet of how medical cannabis is being dispensed across the UK.
The conversation around workers’ rights and medical cannabis is still at a very early stage in the UK.
The UK’s long-running project to regulate CBD (cannabidiol) products has taken another major step forward, seeing thousands of products make it to the final phase of the novel foods approval […]
Researchers from Stellenbosch University have found evidence of rare phenolic compounds in cannabis leaves.